COIN Investigators & Staff - Seattle-Denver Center of Innovation (COIN)
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Seattle-Denver Center of Innovation (COIN)

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
 

COIN Investigators & Staff

COIN Investigators

 

Kamal Henderson, MD
Title: Assistant Professor of Medicine at the University of Colorado School of Medicine
Contact: Kamal.Henderson@va.gov
Location: Denver
See Dr. Henderson's Dimensions profile that includes: publications, grants, datasets, patents and clinical trials

The following images visualize Dr. Henderson's work. The word cloud is drawn from publication titles. The research collaboration map shows research relationships (click the image to enlarge):

Dr. Henderson's publication titles indicate his primary work is care of Veterans
Word cloud from pub titles
Dr. Henderson's collaborations are primarily from the University of Colorado
Research collaboration map
The following research fields have been used to summarize Dr. Henderson's publications and grants. The categories are based on 4 publications and no grants (yet!).
Publications
Clinical Research
Diabetes

Return to Top

Recent Publications

 

2022

 

Henderson KH, Helmkamp LJ, Steiner JF, Havranek EP, Vupputuri SX, Hanratty R, Blair IV, Maertens JA, Dickinson M, Daugherty SL. Relationship Between Social Vulnerability Indicators and Trial Participant Attrition: Findings From the HYVALUE Trial. Circ Cardiovasc Qual Outcomes. 2022 Apr 14:101161CIRCOUTCOMES120007709. doi: 10.1161/CIRCOUTCOMES.120.007709. Epub ahead of print. PMID: 35418247
Learn more about this publication at Dimensions

2021

 

Salahuddin T, Richardson V, McNeal DM, Henderson K, Hess PL, Raghavan S, Saxon DR, Valle JA, Waldo SW, Ho PM, Schwartz GG. Potential unrealized mortality benefit of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transport-2 inhibitors: A report from the Veterans Health Administration Clinical Assessment, Reporting and Tracking program. Diabetes Obes Metab. 2021 Jan;23(1):97-105. doi: 10.1111/dom.14193. Epub 2020 Oct 3. PMID: . PMID: 32902128
Learn more about this publication at Dimensions

McNeal D, Salahuddin T, Valle J, Henderson K, Richardson V, Raghavan S, Saxon D, Hess P, Ho PM, Schwartz GG. (2020). Eligibility for and use of sodium glucose cotransporter-2 inhibitors and glucagon-like peptide-1 agonists in veterans with type 2 diabetes and coronary artery disease: prospective analysis from the cardiac catheterization lab clinical assessment, reporting, and tracking (cart) program. Journal of the American College of Cardiology, Volume 75, Issue 11, Supplement 1. Page 231. ISSN 0735-1097. https://doi.org/10.1016/S0735-1097(20)30858-5
Learn more about this publication at Dimensions

Salahuddin T, McNeal D, Richardson V, Valle J, Henderson K, Raghavan S, Saxon D, Hess P, Ho PM, Schwartz GG. (2020). Potential unrealized cardiovascular benefit of novel diabetes agents in the veterans health administration system: insight from the clinical assessment, reporting, and tracking (cart) program. Journal of the American College of Cardiology. Volume 75, Issue 11, Supplement 1. Page 1836. ISSN 0735-1097. https://doi.org/10.1016/S0735-1097(20)32463-3
Learn more about this publication at Dimensions